more opportunities to prevent mix-ups with osteoporosis meds

July 2012

More safety concerns over bisphosphonates (Actonel, etc) means you'll have more opportunities to prevent mix-ups with osteoporosis meds.

Over 10 million people in North America have osteoporosis.

Many patients don't take their bone-loss meds appropriately...due to administration challenges and safety concerns.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Osteoporosis more opportunities to prevent mix-ups with osteoporosis meds
Antidepressants elderly patients taking more than 10 mg/day of Cipralex (escitalopram) may be at increased risk of heart problems
Overactive Bladder Toviaz (TOE-vee-az, fesoterodine) will add to the confusion in the crowded market of overactive bladder drugs
Pediatrics more emphasis on the prevention and treatment of type 2 diabetes in CHILDREN
Automated Dispensing avoiding mishaps when using automated dispensing devices (Parata, ScriptPro, etc)
Antibiotics Techs will continue to be challenged by Rxs for "cephalosporin" antibiotics
Vitamins & Minerals whether they should STOP taking calcium and vitamin D supplements
Rheumatoid Arthritis Many patients with rheumatoid arthritis will end up taking multiple meds
Elderly Patients "H2-blocker" stomach acid reducers (Zantac, Pepcid, etc) might be inappropriate for elderly patients
Probiotics whether probiotics work for antibiotic-associated diarrhea
Migraine whether Botox and various supplements work to prevent migraine headaches
Photosensitivity some drugs make patients more sensitive to the sun